- MSKCC’s Dr. Howard I. Scher presented results of a study that showed that targeted therapy improves overall in men with advanced PCa.
- MSKCC will be among 4 different research centers tasked with the mission of solving problems related to mesothelioma and treatment for it.
- Dr. Christopher Park of MSKCC is the lead researcher of a study that supports the theory that myelodysplastic syndromes has its origins in bone marrow stem cells.
Category Archives: In the News
Blog Buzz: February 11 – February 17
Some items of interest from the net this week:
Ten library, publishing, and advocacy organizations issued this letter of support for the Senate version of the Federal Research Public Access Act (S. 2096). See more on the Senate and House bills and how you can support FRPAA here.
PubMed now supports versioned citations! For more on how revisions and updates will appear on PubMed and how to search for all versions of an article, see this post from the NLM Tech Bulletin. There is likely more to come about this…
A helpful summary of the American Journal of Bioethics /Stem Cell / Texas scandal (via @tbtam)
The Chronicle of Higher Education reports on changes to the Medical College Admissions Test
Cancer Research News: February 1 – February 14
- Several new drugs for advanced prostate cancer are in development.
- Exemestane, a drug that might prevent breast cancer, also causes bone loss.
- Oral HPV infections, which are more common in men, may lead to head and neck cancers.
- Cyclic peptides from African tea may have anticancer properties.